Clinical Trial Update: Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial comparing itraconazole monotherapy to prednisolone in allergic bronchopulmonary aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• Itraconazole (Sporanox) (Itraconazole)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED